The KEGG enrichment analysis revealed a strong association of the DEGs in the 9c group with the regulation of the p53 signaling pathway, platinum drug resistance, and glioma and axon guidance (Figure 5C). The gene discussed is TP53; the disease is central nervous system cancer.